Skip to main content

注意 - ATTENTION

目前仅LUMINEX LTG部分的内容采用中文表达，所有其它内容依旧提供英文版本

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Chinese.

我们的博客

我们坚信知识就是力量。通过为科学家、研究人员及医疗工作者提供强大工具，助力其实现突破性发现，为患者提供最佳诊疗方案。
本博客作为深度洞见平台，汇聚专业观点与实践应用，全方位展现我们在全球范围内产生的卓越影响力。

Multiplexing Technology Supports Autoantibody Studies for Immuno‑Oncology Treatment

xMAP® Multiplexing

 

 April 22, 2022

Multiplexing Technology Supports Autoantibody Studies for Immuno‑Oncology Treatment

Discover more
The Faces of Luminex: Jill Hutson, Molecular Diagnostics

Faces of Luminex

 April 8, 2022

The Faces of Luminex: Jill Hutson, Molecular Diagnostics

Discover more
Luminex Licensed Technologies Partner Spotlight: Oncimmune®

xMAP® Multiplexing

 

 March 11, 2022

Luminex Licensed Technologies Partner Spotlight: Oncimmune®

Discover more
Buyer’s Guide: How to Choose the Right Multiplex Technology for Your Needs

xMAP® Multiplexing

 

 February 23, 2022

Buyer’s Guide: How to Choose the Right Multiplex Technology for Your Needs

Discover more
Webinar: Designing a COVID-19 Vaccine Efficacy Assay with the xMAP INTELLIFLEX® System

xMAP® Multiplexing

 

 January 24, 2022

Webinar: Designing a COVID-19 Vaccine Efficacy Assay with the xMAP INTELLIFLEX® System

Discover more
BLOG398737.2021.YearinReview.Blog

xMAP® Multiplexing

 

 December 22, 2021

2021 Year in Review: On Why We Do What We Do

Discover more
How Multiplexing Can Support Vaccine Development

xMAP® Multiplexing

 

 December 6, 2021

How Multiplexing Can Support Vaccine Development

Discover more
RD-Biotech Expands Antibody and Immunoassay Services with xMAP® Technology

xMAP® Multiplexing

 

 November 22, 2021

RD-Biotech Expands Antibody and Immunoassay Services with xMAP® Technology

Discover more
Getting Double the Data from Less Sample: An xMAP INTELLIFLEX® Dual Reporter Assay in Action

xMAP® Multiplexing

 

 November 12, 2021

Getting Double the Data from Less Sample: An xMAP INTELLIFLEX® Dual Reporter Assay in Action

Discover more